India faces a rapidly growing burden of metabolic diseases including diabetes, hypertension, obesity, and high cholesterol. A recent study highlights alarming trends across the Asia-Pacific region, with India leading in disease burden. Experts call for urgent nationwide prevention strategies, better nutrition policies, and lifestyle interventions to curb the crisis.
Table of contents [Show]
A recent study published in the peer-reviewed journal Metabolism has highlighted a pressing public health challenge: India and China bear the highest absolute burden of metabolic diseases in the Asia-Pacific region. Drawing from the Global Burden of Disease (GBD) study data covering 1990–2023, with projections to 2030, the analysis (led by Huai Zhang and colleagues) examines five key metabolic conditions and risk factors: type 2 diabetes mellitus (T2DM), high systolic blood pressure (SBP), high body mass index (BMI), high LDL cholesterol, and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as fatty liver disease linked to metabolic issues).
Metabolic diseases arise when the body’s normal processes for breaking down, storing, or using energy from food go awry, often due to poor diet, inactivity, genetics, and environmental factors. These conditions rarely act alone—they interconnect, amplifying risks for heart disease, stroke, kidney failure, and more.
In the Asia-Pacific region overall:
• High SBP led with ~138 million DALYs (disability-adjusted life years, a measure combining years lost to premature death and years lived with disability) and 6.27 million deaths.
• High BMI followed (~55 million DALYs, 1.33 million deaths).
• High LDL cholesterol (~53 million DALYs, 2.02 million deaths).
• T2DM (~49 million DALYs, 1.13 million deaths).
• MASLD had a smaller but notable burden (~1.26 million DALYs, 47,000 deaths).
From 1990 to 2023, total DALYs for these issues rose 1.7- to 3.7-fold, driven by population growth, aging, urbanization, and lifestyle shifts. Absolute burdens were highest in populous nations like China, India, and Indonesia, while relative (per capita) burdens concentrated in Pacific Island nations.
India and China dominate in absolute terms across nearly all parameters. In 2023, India overtook China (which held the top spot in 1990) for overall metabolic disease DALYs in the region.
For India specifically:
• Type 2 diabetes alone accounted for approximately 21 million DALYs and 5.8 lakh (580,000) deaths.
• High systolic blood pressure contributed nearly 3.8 crore (38 million) DALYs and about 15.7 lakh (1.57 million) deaths.
• Rising trends in high BMI (increasing 2.7–2.9% annually), LDL cholesterol, and MASLD add to the crisis.
These figures reflect India’s massive population combined with rapid lifestyle changes—more processed foods, sedentary jobs, and urban stress.
The burden has surged due to interconnected risks: obesity fuels diabetes and hypertension, which in turn worsen cholesterol issues and liver health. In populous countries like India and China, even moderate prevalence rates translate to enormous numbers.
Projections to 2030 indicate continued increases for most conditions (except possibly MASLD), with high SBP remaining dominant—unless aggressive interventions occur.
• Regulate ultra-processed foods.
• Mandate clear front-of-pack nutrition labeling.
• Reduce excess sugar, salt, and unhealthy fats in common foods.
• Promote healthier diets uniformly nationwide.
• Redesign cities and communities for activity: safe walking spaces, cycling tracks, school- and workplace-based exercise programs.
These steps could curb the tide, but require coordinated government, community, and individual efforts. Without them, the human and economic costs—lost productivity, healthcare strain, and premature deaths—will escalate.
This isn’t just a statistic; it’s a wake-up call for the Asia-Pacific’s two largest nations and the region. Metabolic health is foundational to overall well-being. Prioritizing prevention today can secure healthier futures tomorrow.
A new report reveals a surprising gap in Kerala’s healthcare data system. Despite being known for strong health indicators, only 11.41% of registered deaths in the state were medically certified in 2023. This raises serious concerns about mortality data accuracy, disease tracking, and evidence-based public health planning.
ProtoRadNet, an explainable AI model developed at IISER Bhopal, can interpret MRI, CT and X ray scans like a radiologist. Built over 1.5 years and tested on public datasets with 92% accuracy and 190+ clinical reports, the system highlights suspicious regions and explains findings. This innovation could help address India’s radiologist shortage and improve diagnostic speed.
A first-of-its-kind genomic study from India has revealed that the Mpox case detected in Kerala was caused by the Clade Ib variant imported through international travel from Dubai. Genetic sequencing traced the virus’s journey into India, uncovered dangerous mutations, and warned that this evolving strain may spread faster and wider through sustained human transmission.
